Aminoacylase 1 deficiency

From WikiMD's WELLNESSPEDIA


Aminoacylase 1 deficiency
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Developmental delay, Intellectual disability, Seizures
Complications N/A
Onset Infancy
Duration Lifelong
Types N/A
Causes Genetic mutation in the ACY1 gene
Risks N/A
Diagnosis Genetic testing
Differential diagnosis N/A
Prevention N/A
Treatment Supportive care
Medication N/A
Prognosis N/A
Frequency Rare
Deaths N/A


Aminoacylase 1 deficiency is a rare metabolic disorder caused by mutations in the ACY1 gene. This condition is characterized by a range of symptoms including developmental delay, intellectual disability, and seizures.

Genetics[edit]

Aminoacylase 1 deficiency is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The ACY1 gene provides instructions for making an enzyme called aminoacylase 1, which is involved in the breakdown of N-acetylated amino acids.

Symptoms[edit]

The symptoms of aminoacylase 1 deficiency can vary but often include:

Diagnosis[edit]

Diagnosis of aminoacylase 1 deficiency is typically confirmed through genetic testing that identifies mutations in the ACY1 gene. Additional tests may include metabolic screening and neuroimaging to assess the extent of neurological involvement.

Treatment[edit]

There is currently no cure for aminoacylase 1 deficiency. Treatment is focused on managing symptoms and may include:

Prognosis[edit]

The prognosis for individuals with aminoacylase 1 deficiency varies depending on the severity of symptoms. Early intervention and supportive therapies can improve quality of life.

Research[edit]

Ongoing research is focused on understanding the molecular mechanisms of aminoacylase 1 deficiency and developing potential therapies.

See also[edit]

References[edit]


External links[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.